Antiretroviral manufacturers and the challenge of universal access to drugs through the Brazilian National STD/AIDS Program
This article describes the antiretroviral (ARV) manufacturing market in Brazil and contextualizes the challenges for the public policy of supplying ARVs through the National STD/AIDS Program. Increasing expenditure on these drugs is the main source of uncertainty for the policy's future. Brazil's domestic scenario is one of growing external dependence, both for the finished drugs and the active ingredients. Experience in the National Program has shown that it is the state's role to provide public goods, which presupposes ensuring mutual compatibility between company interests and social interests. This balance is currently at stake in Brazil, since structural changes in the market have raised challenges for the National Program's sustainability, requiring new public policy instruments in defense of the collective interest. The article drew on a literature review, using bibliographic indexing sources, systematic organization of primary data, government publications, relevant legislation, research reports, and articles recommended by experts from the field.
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Digital revista |
| Language: | English |
| Published: |
Escola Nacional de Saúde Pública Sergio Arouca, Fundação Oswaldo Cruz
2009
|
| Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2009001000017 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| id |
oai:scielo:S0102-311X2009001000017 |
|---|---|
| record_format |
ojs |
| spelling |
oai:scielo:S0102-311X20090010000172019-02-12Antiretroviral manufacturers and the challenge of universal access to drugs through the Brazilian National STD/AIDS ProgramLago,Regina Ferro doCosta,Nilson do Rosário Anti-Retrovirals Agents Pharmaceutical Services Drug Industry This article describes the antiretroviral (ARV) manufacturing market in Brazil and contextualizes the challenges for the public policy of supplying ARVs through the National STD/AIDS Program. Increasing expenditure on these drugs is the main source of uncertainty for the policy's future. Brazil's domestic scenario is one of growing external dependence, both for the finished drugs and the active ingredients. Experience in the National Program has shown that it is the state's role to provide public goods, which presupposes ensuring mutual compatibility between company interests and social interests. This balance is currently at stake in Brazil, since structural changes in the market have raised challenges for the National Program's sustainability, requiring new public policy instruments in defense of the collective interest. The article drew on a literature review, using bibliographic indexing sources, systematic organization of primary data, government publications, relevant legislation, research reports, and articles recommended by experts from the field.info:eu-repo/semantics/openAccessEscola Nacional de Saúde Pública Sergio Arouca, Fundação Oswaldo CruzCadernos de Saúde Pública v.25 n.10 20092009-10-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2009001000017en10.1590/S0102-311X2009001000017 |
| institution |
SCIELO |
| collection |
OJS |
| country |
Brasil |
| countrycode |
BR |
| component |
Revista |
| access |
En linea |
| databasecode |
rev-scielo-br |
| tag |
revista |
| region |
America del Sur |
| libraryname |
SciELO |
| language |
English |
| format |
Digital |
| author |
Lago,Regina Ferro do Costa,Nilson do Rosário |
| spellingShingle |
Lago,Regina Ferro do Costa,Nilson do Rosário Antiretroviral manufacturers and the challenge of universal access to drugs through the Brazilian National STD/AIDS Program |
| author_facet |
Lago,Regina Ferro do Costa,Nilson do Rosário |
| author_sort |
Lago,Regina Ferro do |
| title |
Antiretroviral manufacturers and the challenge of universal access to drugs through the Brazilian National STD/AIDS Program |
| title_short |
Antiretroviral manufacturers and the challenge of universal access to drugs through the Brazilian National STD/AIDS Program |
| title_full |
Antiretroviral manufacturers and the challenge of universal access to drugs through the Brazilian National STD/AIDS Program |
| title_fullStr |
Antiretroviral manufacturers and the challenge of universal access to drugs through the Brazilian National STD/AIDS Program |
| title_full_unstemmed |
Antiretroviral manufacturers and the challenge of universal access to drugs through the Brazilian National STD/AIDS Program |
| title_sort |
antiretroviral manufacturers and the challenge of universal access to drugs through the brazilian national std/aids program |
| description |
This article describes the antiretroviral (ARV) manufacturing market in Brazil and contextualizes the challenges for the public policy of supplying ARVs through the National STD/AIDS Program. Increasing expenditure on these drugs is the main source of uncertainty for the policy's future. Brazil's domestic scenario is one of growing external dependence, both for the finished drugs and the active ingredients. Experience in the National Program has shown that it is the state's role to provide public goods, which presupposes ensuring mutual compatibility between company interests and social interests. This balance is currently at stake in Brazil, since structural changes in the market have raised challenges for the National Program's sustainability, requiring new public policy instruments in defense of the collective interest. The article drew on a literature review, using bibliographic indexing sources, systematic organization of primary data, government publications, relevant legislation, research reports, and articles recommended by experts from the field. |
| publisher |
Escola Nacional de Saúde Pública Sergio Arouca, Fundação Oswaldo Cruz |
| publishDate |
2009 |
| url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2009001000017 |
| work_keys_str_mv |
AT lagoreginaferrodo antiretroviralmanufacturersandthechallengeofuniversalaccesstodrugsthroughthebraziliannationalstdaidsprogram AT costanilsondorosario antiretroviralmanufacturersandthechallengeofuniversalaccesstodrugsthroughthebraziliannationalstdaidsprogram |
| _version_ |
1756396665846104064 |